BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18494285)

  • 1. [Albumin cobalt binding ability in assessment of myocardial ischemia in patients with acute coronary syndrome].
    Kremneva LV; Kuznetsov VA
    Klin Med (Mosk); 2008; 86(4):40-4. PubMed ID: 18494285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [First experience with the cobalt binding capacity (ACB) test in the diagnosis of acute coronary syndrome (a pilot study)].
    Stejskal D; Lacnák B; Juráková R; Adamovská S; Prosková J; Ochmanová R; Ozanová G
    Vnitr Lek; 2004 Oct; 50(10):734-9. PubMed ID: 15633927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin cobalt binding assay to rule out acute coronary syndrome.
    Abadie JM; Blassingame CL; Bankson DD
    Ann Clin Lab Sci; 2005; 35(1):66-72. PubMed ID: 15830711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of temperature on albumin cobalt binding and its influence on ischemia-modified albumin levels in patients with suspected acute coronary syndrome.
    Hausen BS; Signor C; Kober H; Tatsch E; Pereira RS; Duarte T; Hermes CL; Duarte MM; Moresco RN
    Clin Lab; 2012; 58(1-2):169-72. PubMed ID: 22372361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ischemia-modified albumin: new marker of myocardial ischemia?].
    Dusek J; Tichý M; Stásek J; Bis J; Gregor J; Pudil R; Vojácek J
    Cas Lek Cesk; 2005; 144(5):295-7; discussion 297. PubMed ID: 16013513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.
    Lee YW; Kim HJ; Cho YH; Shin HB; Choi TY; Lee YK
    Clin Chim Acta; 2007 Sep; 384(1-2):24-7. PubMed ID: 17570353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin cobalt binding (ACB) test: its role as a novel marker of acute coronary syndrome.
    Immanuel S; Sanjaya AI
    Acta Med Indones; 2006; 38(2):92-6. PubMed ID: 16799211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ischemia modified albumin--specific marker in cardiological diagnostics?].
    Knapik-Kordecka M; Piwowar A; Zurawska-Płaksej E; Warwas M
    Wiad Lek; 2008; 61(10-12):263-8. PubMed ID: 19323066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of a nickel-albumin binding assay for assessment of myocardial ischaemia.
    da Silva SH; Hausen Bdos S; da Silva DB; Becker AM; de Campos MM; Duarte MM; Moresco RN
    Biomarkers; 2010 Jun; 15(4):353-7. PubMed ID: 20384453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical markers in the diagnosis of acute coronary syndrome].
    Romić E; Unić A; Derek L; Pehar M
    Acta Med Croatica; 2009 Feb; 63(1):15-9. PubMed ID: 19681456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification.
    Zhong Y; Wang N; Xu H; Hou X; Xu P; Zhou Z
    Coron Artery Dis; 2012 Dec; 23(8):538-41. PubMed ID: 22936021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
    Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
    Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation.
    Roy D; Quiles J; Sinha M; Aldama G; Gaze D; Kaski JC
    Am J Cardiol; 2004 Feb; 93(3):366-8. PubMed ID: 14759394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of ischemia-modified albumin in diagnosis of coronary artery disease.
    Kalay N; Cetinkaya Y; Basar E; Muhtaroglu S; Ozdogru I; Gul A; Eryol NK; Oguzhan A; Abaci A
    Coron Artery Dis; 2007 Dec; 18(8):633-7. PubMed ID: 18004114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of the cobalt-albumin binding assay in the diagnosis of intestinal ischemia.
    Polk JD; Rael LT; Craun ML; Mains CW; Davis-Merritt D; Bar-Or D
    J Trauma; 2008 Jan; 64(1):42-5. PubMed ID: 18188097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma.
    Can M; Demirtas S; Polat O; Yildiz A
    Emerg Med J; 2006 Jul; 23(7):537-9. PubMed ID: 16794097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of albumin concentration and serum matrix on ischemia-modified albumin.
    Hakligör A; Kösem A; Seneş M; Yücel D
    Clin Biochem; 2010 Feb; 43(3):345-8. PubMed ID: 19769954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of ischemia-modified albumin level in patients with recurrent pregnancy loss during the first trimester.
    Özdemir S; Kıyıcı A; Balci O; Göktepe H; Çiçekler H; Çelik Ç
    Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):209-12. PubMed ID: 21185113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric inhibition of cobalt binding to albumin by fatty acids: implications for the detection of myocardial ischemia.
    Lu J; Stewart AJ; Sadler PJ; Pinheiro TJ; Blindauer CA
    J Med Chem; 2012 May; 55(9):4425-30. PubMed ID: 22519414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemia modified albumin in the diagnosis of acute coronary syndromes.
    Pantazopoulos I; Papadimitriou L; Dontas I; Demestiha T; Iakovidou N; Xanthos T
    Resuscitation; 2009 Mar; 80(3):306-10. PubMed ID: 19111377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.